On August 1, 2022 Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) reported that Pilot, Inc. (HQ: Kobe, Japan; CEO: Kazuo Maeda), a software firm, has become a wholly-owned subsidiary through the acquisition of outstanding shares and that the company name has changed to Sysmex Pilot Co., Ltd (Press release, Sysmex, AUG 1, 2022, View Source [SID1234617168]). Going forward, the companies aim to improve the speed of development by reinforcing software design and development capabilities.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Pilot has high technical capabilities in control system software development and has established a strong track record in system development for ships, robots, medical equipment and others since its establishment. Pilot started collaborating with Sysmex in 2004 on software design and development for hematology products and transportation systems, thereby contributing to greater efficiency in clinical testing laboratories through automation and acceleration.

With the aim of improving Sysmex’s software design and development capabilities; quality and safety; and product development speed, and also of delivering further synergies, Pilot has become a wholly-owned subsidiary through the acquisition of outstanding shares.

By maximizing the synergies between the two companies and accelerating the software development speed for next-term products, the companies will contribute to the development of healthcare and the healthy lives of people.